Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma tre...
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab
About this item
Full title
Author / Creator
Zhu, Andrew X. , Finn, Richard S. , Kang, Yoon-Koo , Yen, Chia-Jui , Galle, Peter R. , Llovet, Josep M. , Assenat, Eric , Brandi, Giovanni , Motomura, Kenta , Ohno, Izumi , Daniele, Bruno , Vogel, Arndt , Yamashita, Tatsuya , Hsu, Chih-Hung , Gerken, Guido , Bilbruck, John , Hsu, Yanzhi , Liang, Kun , Widau, Ryan C. , Wang, Chunxiao , Abada, Paolo and Kudo, Masatoshi
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Background
Post hoc analyses assessed the prognostic and predictive value of baseline alpha-fetoprotein (AFP), as well as clinical outcomes by AFP response or progression, during treatment in two placebo-controlled trials (REACH, REACH-2).
Methods
Serum AFP was measured at baseline and every three cycles. The prognostic and predictive valu...
Alternative Titles
Full title
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab
Authors, Artists and Contributors
Author / Creator
Finn, Richard S.
Kang, Yoon-Koo
Yen, Chia-Jui
Galle, Peter R.
Llovet, Josep M.
Assenat, Eric
Brandi, Giovanni
Motomura, Kenta
Ohno, Izumi
Daniele, Bruno
Vogel, Arndt
Yamashita, Tatsuya
Hsu, Chih-Hung
Gerken, Guido
Bilbruck, John
Hsu, Yanzhi
Liang, Kun
Widau, Ryan C.
Wang, Chunxiao
Abada, Paolo
Kudo, Masatoshi
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8039038
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8039038
Other Identifiers
ISSN
0007-0920
E-ISSN
1532-1827
DOI
10.1038/s41416-021-01260-w
